First, a kind request if the moderator can correct option E - the "terms" is missing, and it causes some confusion in understanding the sentence. Thanks.
Understanding the argument -
It says that last year, the chemical division's (CD) performance was bad. Earlier, it used to contribute to 60% of the profits. (no further information on CD).
Then it says that the pharmaceutical division's (PD's) earlier contribution was 20%, and now it's 45%, so it is growing stronger.
The argument missed the possibility that the percentages could have changed because the overall pie has reduced. E.g.,
The previous year (before the LY), the profits were as follows: units
CD - 60 units
PD - 20 units
Other Divisions (OD) - 20 units
In overall 100, PD's contribution is 20%
LY
CD - 4 units
PD - 20 units
Other Divisions (OD) - 20 units
In overall 44, PD's contribution is 45%
Did the PD grow stronger? No. It performed the same. But just because the overall profit declined, the PD percentage looks better. And that's what option C highlights.
Option Elimination -
(A) The increase in the pharmaceutical division's contribution to corporation profits could have resulted largely from the introduction of single, important new product. We aren't even going there yet. First, we ask the basic question, "Did the PD grow"? So, this option is out of scope.
(B) In multidivisional corporations that have pharmaceutical divisions, over half of the corporation's profits usually come from the pharmaceuticals. Doesn't matter what happens in other multinational corporations; it is out of scope.
(C) The percentage of the corporation's profits attributable to the pharmaceutical division could have increased even if that division's performance had not improved. - Yes, that's what we highlighted.
(D) The information cited does not make it possible to determine whether the 20 percent share of profits cited was itself an improvement over the year before. The improvement over the year before is out of scope.
(E) The information cited does not make it possible to compare the performance of the chemical and pharmaceutical divisions in terms of the percent of total profits attributable to each. - The issue with this option is that while it tells the truth, it is still possible that the PD grew.
Let me share that with an example -
LY (Scenario 1) - PD doesn't grow
CD - 4 units - 4%
PD - 20 units - 45%
Other Divisions (OD) - 20 units
In overall 44, PD's contribution is 45
LY (Scenario 2) - PD grows
CD - 8 units - 4%
PD - 90 units - 45%
Other Divisions (OD) - 102 units
Overall, PD's contribution is 45
So, saying "does not make it possible" is something we can't say with 100% confidence. The data may or may not have helped. On the contrary, option C directly finds a flaw, citing Scenario 1.